Skip to content

ARCOM

Active Private limited companyfounded 2006active for 20 yearsDe Sevillastraat 91, 2100 AntwerpKBO/BCE: BE 0879.916.197
ARCOM
Follow ReportCompare

Overview

Lifetime

19 annual accounts with figures on one time axis
peak €94,272 (2020)
€10,090▲ 15.0%
lowest -€104,564 (2010)
€4,987▼ 19.3%
peak €197,642 (2021)
€127,062▼ 34.1%
€14,076▲ 17.7%
peak 3 FTE (2008)
-not published
Board2 names since 2021
1 directorLemmens Lieve
Owners2 names in the annual accounts
  
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €8,776 to €10,090Equity from €192,884 to €127,062Debts from €11,962 to €14,076

Key points

from the 2025 annual accounts

Equity

€127,062 ▼ 34.1%
€193,0002024€127,0002025

Equity fell in 2025 from €192,884 to €127,062.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Ten of the last ten came late. The 2019 accounts came latest: 119 days after the end of the period.

Position in the sector

€4,987

Lower net result than 87% of companies in human health. Sector median €60,073 · 20,761 companies.

Checked score

94
Excellent
Financially stronger than 53% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100=equity 90.0% of total assets
100=short-term debt 10.0% · cash 83.0%
73=return on assets 3.5%

Score breakdown

raises risk
Last filed accounts filed 31 days late; 2 of the last 3 accounts late
lowers risk
Liquidity: current ratio 9.42, cash €117,118
Sector: Human health activities (NACE 86)
Equity €127,062 (90.0% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 17% on profitability and 16% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 17,041 companies had the same profile as ARCOM has now. Each dot stands for 43 companies, two years later.

94.4%
were still trading
4.9%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.2% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of ARCOM itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,041 companies, not a prediction for ARCOM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €11,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 9.42 (16.14 in 2024), above the usual 1.5. Short-term debt is 10% and cash 83% of total assets. 10% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 9.42, cash €117,118
NBB · annual accounts
raises risk · Last filed accounts filed 31 days late; 2 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €127,062 (90.0% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
99 days late
2023
29 days late
2022
30 days late
2021
31 days late
2020
27 days late
2019
119 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 52 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

LL
Lemmens Lieve
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0879916197
Change of role: Lieven Lemmens, from manager to director Legal-form conversion: from private limited company (pre-2019) to private limited company · Director discharge: Lieven Lemmens · Gazette deed
First establishment ARCOM SCIENTIFIC, De Sevillastraat 91, Antwerp
Incorporation published on 23-03-2006 · Gazette deed
All 33 events

Comparable companies

same main activity, similar in size and age
Company
ARCOM Antwerp €141,138 €10,090 90.0% -
Clinical Trial Advising Bureau Kampenhout €118,166 €8,134 88.9% -
DOKTER NUYTTENS FILIP Izegem €268,710 €12,946 99.6% -
PROF.DR.BEULS Hasselt €172,741 €27,266 97.5% -
Dokter Bert Hannosset Leuven €75,371 €23,531 90.1% -
Dr.A.VAN ACKER NEUROPSYCHIATRIE Ixelles €343,220 €21,267 83.8% -
Phytocontrol Analytics Belgium Brussels €235,638 €16,836 27.3% 0

These companies have the same main activity as ARCOM: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €75,400 and €343,000, founded between 1996 and 2017.

Official details

Source: KBO
Status
Active since 10-03-2006Normal situation
Activity
Medical imaging and medical laboratoriesNACE 86910and 4 others
Establishment unit
2.152.493.1482100 Antwerp, since 27-03-2006
Financial year end
31 December
Peppol
Reachable since 01-04-2025
Company details

Annual accounts 2025

€10,090▲ 15.0%
≈ €59,000estimated
€4,987▼ 19.3%
€127,062▼ 34.1%
€141,138▼ 31.1%
Filing
Filed on 31-08-2026
Financials

Insights on ARCOM

ARCOM files the micro format. That format states no turnover. The gross margin fell from €26,182 in 2007 to €10,090 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 31-08-2026, 31 days late
€10,090
▲ 15.0%
€6,041
▲ 13.7%
€4,987
▼ 19.3%
€118,514
▼ 34.6%
90.0%
▼ 4.1 percentage points
9.42
▼ 6.72

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €59,000. Estimated: probably between €40,000 and €110,000.

Balance sheet

balance sheet total €141,138 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

90.0%

Higher than 84% of 20,774 companies in 2025.

9.42

Higher than 82% of 20,348 companies in 2025.

3.5%

Higher than 13% of 20,630 companies in 2025.

ARCOM Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: bottom quarter · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Staff

Staff costs divided by the average number of full-time equivalents.

people who joined people who left

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019201820172016201520142013201220112010200920082007
Balance sheet: assets
20/58 141,138204,847202,543203,153213,179207,688157,059127,420101,49679,58346,56724,03025,1853,2864,93658,26066,70912,36240,588
21/28 8,54811,80311,39514,1646,547---1,3743,6986,6928,74511,4263533874211,2171,7633,852
21 ------------------139
22/27 8,54811,80311,39514,1646,547---1,3743,6986,6928,74511,4261031371719671,7633,713
23 8,54811,80311,39513,6235,424----314627-----6751,3503,118
24 ---5411,123---1,3743,3846,0658,74511,426---87174304
26 -------------103137171206240291
28 -------------250250250250--
29/58 132,590193,044191,147188,989206,632207,688157,059127,420100,12275,88539,87615,28513,7602,9334,54957,83965,49110,59936,735
40/41 15,10881,55783,87486,343100,92686,052129,475117,59189,31861,23635,89812,78111,1758482,80332,98943,6856,32110,402
40 15,01414,42713,17812,03326,11010,89649,52756,15642,19428,9809,4095,2435,247-2,4431791,5491,0699,175
41 9367,13070,69674,31174,81675,15579,94861,43547,12432,25726,4897,5385,92884836032,81042,1375,2521,227
54/58 117,118111,138106,939102,320105,378121,30827,2559,05210,35514,6493,9782,5042,5852,0851,74618,70218,1464,13126,333
490/1 364348333326328328329777449------6,1473,660146-
Balance sheet: equity and liabilities
10/49 141,138204,847202,543203,153213,179207,688157,059127,420101,49679,58346,56724,03025,1853,2864,93658,26066,70912,36240,588
10/15 127,062192,884186,707185,225197,642195,366144,558119,62993,20471,52636,6247,3736,351-3,925-35,55938,3059,870-50,22921,029
10/11 115,756363,600363,600363,600363,600363,600363,600363,600363,600363,600363,600363,600363,600363,600258,600258,600125,60018,60018,600
100 ------363,600363,600363,600363,600363,600363,600363,600363,600258,600258,600258,60018,60018,600
101 ----------------133,000--
13 5,1291421421421421421421421421421421421421421421421421422,429
130/1 142142142142142142-------------
130 ------142142142142142142142142142142142142142
1311 142142142142142142-------------
133 4,987-----------------2,287
14 6,177-170,858-177,035-178,517-166,100-168,377-219,185-244,113-270,538-292,216-327,118-356,369-357,392-367,667-294,301-220,437-115,873-68,971-
17/49 14,07611,96215,83617,92815,53712,32212,5017,7918,2928,0569,94316,65718,8347,21140,49519,95556,83962,59019,558
42/48 14,07611,96215,83617,92815,53712,32212,5017,7918,2928,0569,94316,61118,8347,21138,64219,95556,83961,84018,808
43 23952311111111------------
430/8 23952311111111------------
44 2,8632,5986,16613,29113,5423,4822,6514,5116,5835,1987,69112,643577-9285,28015,8556,06314,394
440/4 2,8632,5986,16613,29113,5423,4822,6514,5116,5835,1987,69112,643577-9285,28015,8556,06314,394
45 7,3289,2699,6464,6261,9858,8299,8403,2801,7092,8582,2523,96812,079-2,5423,29213,79312,5474,230
450/3 7,3289,2699,6464,6261,9851,8292,8403,2801,7092,8582,2523,96812,079---4,2503,946419
454/9 -----7,0007,000-------2,5423,2929,5438,6013,812
47/48 3,862-----------6,1787,21135,17211,38327,19143,230184
492/3 -----------46--1,853--750750
Income statement
9900 10,0908,7765,126-8,8544,16494,27234,14228,84224,61139,02533,2955,50817,510-72,728-73,060-101,055-44,239-1,10526,182
62 ----------------28722,35367,21719,123
630 3,2552,6752,7682,489702---2,3242,9942,9942,6812,68134347967962,0893,374
640/8 7947876648723397154481,2735028191,0037787625507081,133556496801
66A -------1,374----96--12510,000--
9901 6,0415,3141,694-12,2153,12393,55633,69426,19521,78535,21229,2982,04914,067-73,313-73,801-102,697-67,943-70,9072,883
75/76B 61,039371601015585515603251391123855
75 61,039371601015585515603251391123855
65/66B 153175249219164171838-174116365481,1531871051011,75166338986
65 153175249219164171838-174116365481,1531871051011,75166338986
9903 5,8936,1771,482-12,4172,95893,39532,85726,42521,67834,90229,2511,45613,817-73,366-73,864-104,563-78,604-71,2582,853
67/77 907---68242,5867,928----4343,541--20-423
9904 4,9876,1771,482-12,4172,27650,80824,92926,42521,67834,90229,2511,02210,276-73,366-73,864-104,564-78,605-71,2582,429
9905 4,9876,1771,482-12,4172,27650,80824,92926,42521,67834,90229,2511,02210,276-73,366-73,864-104,564-78,605-71,2582,429
Appropriation of the result
9906 11,164-170,858-177,035-178,517-166,100-168,377-219,185-244,113-270,538-292,216-327,118-356,369-357,392-367,667-294,301-220,437-147,576-71,2582,429
14P 6,177-177,035-178,517-166,100-168,377--------------
791/2 -----------------2,287-
691/2 4,987-----------------2,429
6920 ------------------142
6921 4,987-----------------2,287
Social balance sheet
9087 ----------------0.930.5
Hours worked1013 ----------------7912,386705
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 4 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 31-08-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 31 days after the deadline. Filed on 31 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00459383.

Financial year Type Filed Reference Document
31-12-2025 micro format 31-08-2026 2026-00459383 PDF
31-12-2024 micro format 07-11-2025 2025-00563893 PDF
31-12-2023 micro format 29-08-2024 2024-00409528 PDF
31-12-2022 micro format 30-08-2023 2023-00431459 PDF
31-12-2021 micro format 31-08-2022 2022-20413162 PDF
31-12-2020 micro format 27-08-2021 2021-56800241 PDF
31-12-2019 micro format 27-11-2020 2020-72800224 PDF
31-12-2018 micro format 28-10-2019 2019-71500599 PDF
31-12-2017 micro format 28-09-2018 2018-67500389 PDF
31-12-2016 micro format 10-08-2017 2017-43100338 PDF
31-12-2015 abbreviated format 09-08-2016 2016-41100088 PDF
31-12-2014 abbreviated format 31-08-2015 2015-54200319 PDF
31-12-2013 abbreviated format 30-09-2014 2014-63800430 PDF
30-09-2012 abbreviated format 18-12-2012 2012-67000128 PDF
30-09-2011 abbreviated format 29-02-2012 2012-05000056 PDF
30-09-2010 abbreviated format 11-03-2011 2011-05600480 PDF
30-09-2009 abbreviated format 27-04-2010 2010-10000080 PDF
30-09-2008 abbreviated format 30-04-2009 2009-12900376 PDF
30-09-2007 abbreviated format 24-04-2008 2008-11600188 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019201820172016201520142013201220112010200920082007
9,2957,9894,462-9,7263,824---24,10938,20632,2924,73016,748-73,278-73,767-101,901-67,147-68,8186,257
8,2418,8524,250-9,9292,978---24,00237,89632,2453,70312,956-73,332-73,830-103,769-77,809-69,1695,803
03,083010,1057,249---00941014,10600025007,226
5,9804,1994,620-3,058-15,93094,05318,203-1,303-4,29410,6711,474-81499340-16,95755614,015-22,202-
118,514181,081175,312171,061191,095195,366144,558119,62991,83067,82929,932-1,326-5,075-4,278-34,09337,8848,653-51,24217,927
90.0%94.2%92.2%91.2%92.7%94.1%92.0%93.9%91.8%89.9%78.6%30.7%25.2%--65.7%14.8%-406.3%51.8%
9.4216.1412.0710.5413.3016.8612.5616.3512.079.424.010.920.73--2.901.150.171.95
0.110.060.080.100.080.060.090.070.090.110.272.262.97--0.525.76-0.93
3.9%3.2%0.8%-6.7%1.2%26.0%17.2%22.1%23.3%48.8%79.9%13.9%161.8%---273.0%-796.4%-11.6%
3.5%3.0%0.7%-6.1%1.1%24.5%15.9%20.7%21.4%43.9%62.8%4.3%40.8%---179.5%-117.8%-576.4%6.0%
60.8145.7017.92-44.4623.26--------------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets-€3,083-€10,105€7,249
€3,255€2,675€2,768€2,489€702

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on ARCOM

The operating result for 2025 is 14% higher than in 2024 and the highest since 2020. It is the third rise in a row, after the fall in 2022.

Debt's share of the balance-sheet total rises from 5.8% to 10.0%. Equity is lower and debt is higher.

Board & ownership

Board

1 director, last change in 2024
Lemmens Lieve
Director
listed in the 2025 annual accounts, filed on 31-08-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Artikel 14. Bevoegdheden van het bestuursorgaan Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de bestuurders aan…”
deed of 05-11-2024

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
Lemmens Lieve
Director
Lieven Lemmens
Director (not named in the articles)
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • Lemmens Lieve
    • Director, since before 31-12-2021
  • Lieven Lemmens
    • Director (not named in the articles), appointed by deed of 05-11-2024, no longer listed in the 2025 annual accounts

See the board, name and registered office on a given date →

Control

Shareholder in 2012
Advanced Practical Diagnostics
32%
This company
ARCOM
Equity €127,062
Profit €4,987 in 2025

Capital

Contribution
€115,755.91
Shares
300
Contribution per share
€386
Equity per share
€424 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Advanced Practical Diagnostics
32%
32%
HOVE
5%
5% until 2011
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 05-11-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Friday of May at 16:00

Network & group

No group

ARCOM has no parent and no holdings in its annual accounts. Lemmens Lieve is the only director. ARCOM shares no director with another company.

At the same address

De Sevillastraat 91, 2100 Antwerp · 1 other company
WATERPOLOKAMPEN.BE
registered office since 10-10-2010
 founded in 2010
0830.418.978

Timeline

Timeline

33 events since 2006

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 31 days late
2025
Annual accounts 2024 filed PDFmicro format · 99 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0879916197
2024
Change of role: Lieven Lemmens, from manager to directorLegal-form conversion: from private limited company (pre-2019) to private limited company · Director discharge: Lieven Lemmens6 points ▸
  • Legal-form conversion, from private limited company (pre-2019) to private limited company
  • Director resignation, Lieven Lemmens (manager)
  • Director appointment, Lieven Lemmens (director (not named in the articles))
  • Director discharge, Lieven Lemmens
  • 300 shares
  • Power of attorney, Stephane Van Roosbroeck
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2023 filed PDFmicro format · 29 days late
2023
Back to profit net €1,482 The net result is €1,482, after one loss-making year.
Annual accounts 2022 filed PDFmicro format · 30 days late
2022
Annual accounts 2021 filed PDFmicro format · 31 days late
2021
Annual accounts 2020 filed PDFmicro format · 27 days late
2020
Highest result from 2007 to 2025 net €50,808 ▲104% The operating result of €93,556 and the net result of €50,808 are both a record.
Equity above €150,000 equity €195,366 ▲35.1% After 8 profitable years in a row, equity reaches €195,366.
Annual accounts 2019 filed PDFmicro format · 119 days late
2019
Annual accounts 2018 filed PDFmicro format · 89 days late
2018
Equity above €100,000 equity €119,629 ▲28.4% After 6 profitable years in a row, equity reaches €119,629.
Annual accounts 2017 filed PDFmicro format · 59 days late
2017
Annual accounts 2016 filed PDFmicro format · 10 days late
2016
Liquidity more than doubled current ratio 9.42 The current ratio rises from 4.01 to 9.42. Short-term debt falls from €9,943 to €8,056.
Annual accounts 2015 filed PDFabbreviated format · 9 days late
2015
Liquidity more than quadruples current ratio 4.01 The current ratio rises from 0.92 to 4.01. Short-term debt falls from €16,611 to €9,943.
Annual accounts 2014 filed PDFabbreviated format · 31 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 61 days late
2013
Back to profit net €10,276 The net result is €10,276, after 5 loss-making years.
2012
Annual accounts 2012 filed PDFabbreviated format · 133 days before the deadline
Annual accounts 2011 filed PDFabbreviated format · 61 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 50 days before the deadline
2010
Weakest financial year net -€104,564 The net result drops to -€104,564, the lowest from 2007 to 2025. It recovers the following year.
Liquidity more than doubled current ratio 2.90 The current ratio rises from 1.15 to 2.90. Short-term debt falls from €56,839 to €19,955.
Annual accounts 2009 filed PDFabbreviated format · 3 days before the deadline
2009
Liquidity more than 6 times current ratio 1.15 The current ratio rises from 0.17 to 1.15. Short-term debt falls from €61,840 to €56,839.
Annual accounts 2008 filed PDFabbreviated format · on the deadline day
2008
Annual accounts 2007 filed PDFabbreviated format · 6 days before the deadline
2006
First establishment ARCOM SCIENTIFIC, De Sevillastraat 91, Antwerp
Incorporation PDFpublished on 23-03-2006

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

ARCOM was incorporated on 10 March 2006.1 Total assets rose from €127,420 in 2018 to €141,138 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Company details

Identity

Enterprise number
0879.916.197
VAT number
BE 0879.916.197
Peppol ID
0208:0879916197
Other Peppol ID
9925:BE0879916197
Legal form
Private limited company
Status
Active, normal situation
Founded
10-03-2006
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Friday of May at 16:00
deed of 05-11-2024 (in Dutch)
Peppol
Reachable since 01-04-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
ARCOM in Dutch
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 05-11-2024 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 05-11-2024 (in Dutch)

Activities

NACEBEL 2025
86910 Medical imaging and medical laboratories main activity
21100 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201 Manufacture of basic pharmaceutical products and pharmaceutical preparations
72109 Other research and development on natural sciences
86995 Nutrition and dietetics services
Codes under NACEBEL 2008
86901 Human health activities main activity
21100 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201 Manufacture of basic pharmaceutical products and pharmaceutical preparations
72190 Scientific research and development
86909 Human health activities
Codes under NACEBEL 2003
85141 main activity
24410
24421
73100
85146
PurposeThe purpose describes the activities the company may carry out under its articles.
“Ondersteuning van bedrijven die confectie willen aankopen of produceren, middels het leveren van patronen, modellen, gradaties en…”
6 activities
  1. Ondersteuning van bedrijven die confectie willen aankopen of produceren, middels het leveren van patronen, modellen, gradaties en intekeningen, alsook het opstellen van productspecificaties, matentabellen en lastenboeken en productierichtlijnen. Verder de begeleiding van derden bij selectie van modellen en pasvorm, het kiezen van patronen, productie van de eerste modellen en het opstarten van de productie van kleding;
  2. De aankoop en verkoop, de fabricatie van allerlei textiel -, confectie – en gelijkaardige producten zowel in binnen- en buitenland. Tevens ook de vertegenwoordiging en de commissie van deze artikelen;
  3. Het verhuur van kledij en textiel en tenten, en alle toebehoren;
  4. Het optreden als redder in een zwembad, zowel binnen als buiten;
  5. Het stellen, aanvaarden, verlenen, uitvoeren van alle verrichtingen van mandaat, beheer over, van commissie aangaande, van beleggen van, van dienstverlening in verband met alle wel danige roerende en onroerende goederen. De vennootschap mag het beheer, de directie, de coördinatie, de leiding en het toezicht uitoefenen en bijstand verlenen aan vennootschappen, ondernemingen, groeperingen, instellingen of hun activiteiten onder welke vorm ook;
  6. Het verlenen en toestaan van leningen en kredietopeningen van gelijk welke aard, doch echter geen gereglementeerde verrichtingen, het verlenen van borgtochten, zakelijk roerende en onroerende zekerheden ten voordelen van de vennootschap, ondernemingen, instellingen en deren van gelijk welke aard en onder gelijk welke vorm.
deed of 05-11-2024 (in Dutch)

Registered office and establishments

1 establishment
Establishment Since Unit number
ARCOM SCIENTIFIC registered office De Sevillastraat 91, 2100 Antwerp 27-03-2006 2.152.493.148

Buildings and parcels at the address

Ground area
177 m²
Buildings
82 m²
Volume, LiDAR
555 m³
Tallest building
8.8 m
Buildings to scale, each on its own parcel
82 m², 8.8 m 82 m², 8.8 m

Location

registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
11346B0982/00S014177 m² 1 · 82 m² 8.8 m · 2

We would like to set cookies. That happens only with your consent. What we measure